We are live on ! Find out more
AV

ASR Vermogensbeheer Portfolio holdings

AUM $9.71B
1-Year Est. Return 37.32%
This Fund
S&P 500
This Quarter Est. Return
+24.73%
1 Year Est. Return
+37.32%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$9.71B
AUM Growth
+$1.2B
Cap. Flow
+$2.83M
Cap. Flow %
0.03%
Top 10 Hldgs %
34.33%
Holding
569
New
37
Increased
211
Reduced
212
Closed
109

Top Buys

Rank Stock Value
1
UBS icon
UBS Group
UBS
+$49.4M
2
KLAC icon
KLA
KLAC
+$48.6M
3
GM icon
General Motors
GM
+$23.4M
4
MU icon
Micron Technology
MU
+$19.8M
5
MET icon
MetLife
MET
+$17.2M

Top Sells

Rank Stock Value
1
NKE icon
Nike
NKE
+$33M
2
JPM icon
JPMorgan Chase
JPM
+$20.7M
3
NVDA icon
NVIDIA
NVDA
+$20.3M
4
WELL icon
Welltower
WELL
+$19M
5
ABT icon
Abbott
ABT
+$18.4M

Sector Composition

Rank Sector Weight
1 Technology 34.76%
2 Financials 13.8%
3 Healthcare 11.5%
4 Communication Services 10.15%
5 Consumer Discretionary 9.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RMD icon
351
ResMed
RMD
$32.9B
$2.2M 0.02%
11,290
-1,539
-12% -$319K
IQV icon
352
IQVIA
IQV
$44.1B
$2.18M 0.02%
11,259
+492
+5% +$85.8K
CLS icon
353
Celestica
CLS
$39.4B
$2.16M 0.02%
5,930
-313
-5% -$117K
CW icon
354
Curtiss-Wright
CW
$20.9B
$2.15M 0.02%
+2,843
New +$2.08M
CPRT icon
355
Copart
CPRT
$31.2B
$2.13M 0.02%
75,658
+67,015
+775% +$2.16M
EMR icon
356
Emerson Electric
EMR
$85.2B
$2.09M 0.02%
14,619
-72,918
-83% -$10.3M
FOXA icon
357
Fox Class A
FOXA
$27.5B
$2.08M 0.02%
39,805
+6,252
+19% +$386K
RDDT icon
358
Reddit
RDDT
$29.7B
$2.05M 0.02%
11,816
+2,870
+32% +$460K
SBAC icon
359
SBA Communications
SBAC
$20.1B
$2.02M 0.02%
11,461
+5,607
+96% +$1.16M
AFRM icon
360
Affirm
AFRM
$24.4B
$1.98M 0.02%
24,289
+19,118
+370% +$1.25M
KIM icon
361
Kimco Realty
KIM
$15.8B
$1.95M 0.02%
77,066
+45,831
+147% +$1.1M
STT icon
362
State Street
STT
$53.4B
$1.95M 0.02%
11,470
-66,957
-85% -$10.3M
TEVA icon
363
Teva Pharmaceuticals
TEVA
$42.4B
$1.94M 0.02%
57,395
+22,780
+66% +$759K
WAB icon
364
Wabtec
WAB
$47.8B
$1.94M 0.02%
7,206
-20,337
-74% -$5.38M
CSL icon
365
Carlisle Companies
CSL
$14B
$1.9M 0.02%
5,231
+4,572
+694% +$1.6M
LH icon
366
Labcorp
LH
$26.5B
$1.87M 0.02%
6,692
+3,120
+87% +$820K
NTR icon
367
Nutrien
NTR
$37.9B
$1.81M 0.02%
28,779
+10,059
+54% +$703K
FTV icon
368
Fortive
FTV
$17.2B
$1.76M 0.02%
28,830
-25,836
-47% -$1.55M
SLF icon
369
Sun Life Financial
SLF
$45.1B
$1.76M 0.02%
22,391
+307
+1% +$22.1K
REG icon
370
Regency Centers
REG
$13.8B
$1.75M 0.02%
21,991
-2,697
-11% -$212K
BCE icon
371
BCE
BCE
$22.1B
$1.74M 0.02%
80,907
+73,700
+1,023% +$1.77M
XPO icon
372
XPO
XPO
$22.6B
$1.74M 0.02%
+8,464
New +$1.79M
FFIV icon
373
F5
FFIV
$22.1B
$1.74M 0.02%
4,175
+1,299
+45% +$462K
A icon
374
Agilent Technologies
A
$42.5B
$1.74M 0.02%
13,065
-35,557
-73% -$4.33M
NDSN icon
375
Nordson
NDSN
$17.7B
$1.68M 0.02%
5,565
+4,160
+296% +$1.18M

Similar funds

ASR Vermogensbeheer's Q2 2026 Portfolio in Review

As of Q2 2026, ASR Vermogensbeheer held 569 positions worth $9.71B, up 14% from $8.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

ASR Vermogensbeheer's Q2 2026 filing shows 37 new, 211 increased, 212 reduced and 109 closed positions. Its largest new stake was General Motors: 297,365 shares worth $22.9M. The largest sale was Nike, an estimated $33M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 31% a quarter earlier, followed by Financials and Healthcare.

  • ASR Vermogensbeheer's largest Q2 2026 buy was General Motors: 297,365 shares worth $22.9M.
  • ASR Vermogensbeheer added most to UBS Group in Q2 2026, an estimated $49.4M increase.
  • ASR Vermogensbeheer's biggest Q2 2026 reduction was JPMorgan Chase, cutting an estimated $20.7M.
  • ASR Vermogensbeheer fully exited Nike in Q2 2026, selling an estimated $33M.
  • ASR Vermogensbeheer's ten largest holdings make up 34% of its $9.71B portfolio in Q2 2026.
  • ASR Vermogensbeheer opened 37 new positions and closed 109 in Q2 2026.
  • ASR Vermogensbeheer's portfolio value rose 14% quarter-over-quarter to $9.71B.

Based on ASR Vermogensbeheer's 13F filing for Q2 2026, filed 20 Jul 2026.